Cargando…

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope

Pharmacological management has advanced considerably since the 2015 British Society for Rheumatology axial spondyloarthritis (axSpA) guideline to incorporate new classes of biologic DMARDs (bDMARDs, including biosimilars), targeted synthetic DMARDs (tsDMARDs) and treatment strategies such as drug ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Sizheng Steven, Harrison, Stephanie R, Chan, Antoni, Clarke, Nick, Davis, Charlotte, Eddison, Joe, Gregory, William J, Jones, Gareth T, Marzo-Ortega, Helena, Murphy, Daniel J, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan, Thompson, Ben, Webb, Dale, Yates, Max, Gaffney, Karl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183299/ https://www.ncbi.nlm.nih.gov/pubmed/37197377 http://dx.doi.org/10.1093/rap/rkad039

Ejemplares similares

Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry
por: Michelena, Xabier, et al.
Publicado: (2021)

Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis
por: Derakhshan, Mohammad H, et al.
Publicado: (2020)

Korean treatment recommendations for patients with axial spondyloarthritis
por: Seo, Mi Ryoung, et al.
Publicado: (2023)

Defining the target: clinical aims in axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2018)

Management of systemic sclerosis: British Society for Rheumatology guideline scope
por: Denton, Christopher P, et al.
Publicado: (2023)

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
por: Truong, Steven L., et al.
Publicado: (2021)

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
por: Schreiber, Karen, et al.
Publicado: (2022)

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
por: Oldroyd, Alexander G S, et al.
Publicado: (2022)

Management of foot health in people with inflammatory arthritis: British Society for Rheumatology guideline scope
por: Chapman, Lara S, et al.
Publicado: (2022)

Axial spondyloarthritis: coming of age
por: Marzo-Ortega, Helena
Publicado: (2020)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis
por: Provan, Sella A, et al.
Publicado: (2021)

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2023)

COVID-19 in axial spondyloarthritis care provision: helping to straighten the long and winding road
por: Marzo-Ortega, Helena, et al.
Publicado: (2021)

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
por: Russell, Mark D, et al.
Publicado: (2022)

Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis
por: Shim, Joanna, et al.
Publicado: (2018)

Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis
por: Wei, James Cheng‐Chung, et al.
Publicado: (2019)

Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
por: Harrison, S. R., et al.
Publicado: (2023)

Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference
por: Sepriano, Alexandre, et al.
Publicado: (2021)

Correction to: Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
por: Harrison, S. R., et al.
Publicado: (2023)

Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care
por: Poddubnyy, Denis, et al.
Publicado: (2018)

Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis
por: Yahya, Fariz, et al.
Publicado: (2019)

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2019)

Association between comorbidities and disease activity in axial spondyloarthritis: results from the BSRBR-AS
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2021)

Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis
por: Zhao, Sizheng, et al.
Publicado: (2016)

Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study
por: Zhao, Sizheng, et al.
Publicado: (2018)

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
por: Robinson, Philip C., et al.
Publicado: (2019)

The prevalence of fibromyalgia in axial spondyloarthritis
por: Jones, Gareth T., et al.
Publicado: (2020)

British Thoracic Society guideline for bronchiectasis in adults
por: Hill, Adam T, et al.
Publicado: (2018)

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
por: Kennedy, Nicholas A, et al.
Publicado: (2020)

Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
por: G.S. Saad, Carla, et al.
Publicado: (2023)

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
por: Lamb, Christopher Andrew, et al.
Publicado: (2019)

Consensus on targeted drug therapy for spondyloarthritis
por: Tian, Xinping, et al.
Publicado: (2023)

Clinical indications and triaging for adult transthoracic echocardiography: a consensus statement by the British Society of Echocardiography in collaboration with British Heart Valve Society
por: Bennett, Sadie, et al.
Publicado: (2022)

Corrigendum to: Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Thrombophilia testing: A British Society for Haematology guideline
por: Arachchillage, Deepa J., et al.
Publicado: (2022)

British Society of Gastroenterology guidelines on the management of functional dyspepsia
por: Black, Christopher J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hsdr2o7guvd6hpidih88bp447u